Search for: "M.D. Janet Woodcock" Results 1 - 20 of 59
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2023, 6:25 pm by Kurt R. Karst
FDA Principal Deputy Commissioner Janet Woodcock, M.D. issued the release on January 26th stating that she had chaired an FDA “high-level internal working group to explore potential regulatory pathways for CBD products. [read post]
26 Jan 2023, 2:06 pm by Cassie J. Edgar
This working group, led by FDA Principal Deputy Commissioner Janet Woodcock, M.D., has closely examined the existing scientific data related to CBD, including studies related to the CBD-based drug Epidiolex, published scientific literature, information submitted to a public docket, and studies both conducted and commissioned by the agency. [read post]
31 May 2022, 12:39 pm by Ana Popovich
After a February recall of powdered infant formula manufactured in an Abbott Laboratories facility in Sturgis, Michigan, parents across the U.S. have struggled to find formulas and been confronted by empty shelves. [read post]
2 Oct 2021, 8:35 am by Bill Marler
“The FDA plays a critical role in safeguarding the U.S. food supply and helping to ensure that our food is not contaminated at any point during its journey along the supply chain,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
1 Oct 2021, 9:05 pm by Coral Beach
“The FDA plays a critical role in safeguarding the U.S. food supply and helping to ensure that our food is not contaminated at any point during its journey along the supply chain,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
21 Sep 2021, 9:02 pm by News Desk
According to acting FDA Commissioner Janet Woodcock, M.D., “Good data management, built into all of our work, ultimately helps us meet and advance the FDA’s mission to ensure safe and effective products for American families. [read post]
On September 10, 2021, the Acting Commissioner of Food and Drugs, Janet Woodcock, M.D., and Director of the Center for Biologics Evaluation and Research, Peter Marks, M.D., PhD., issued a statement on behalf of the FDA regarding the vaccination of children under the age of twelve. [read post]
20 Jul 2021, 3:21 pm by Dan Flynn
In FDA Voices, Janet Woodcock, M.D., Acting Commissioner of Food and Drugs, and Yiannas, Deputy Commissioner for Food Policy and Response provided details. [read post]
13 Jul 2021, 9:03 pm by Guest Contributor
Opinion By Janet Woodcock, M.D., Acting Commissioner of Food and Drugs, and Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response One year ago the U.S. [read post]
10 Jun 2021, 9:03 pm by Guest Contributor
Editor’s note: Following is a letter signed by a coalition of organizations and sent to Janet Woodcock, M.D., FDA Acting Commissioner of Food and Drugs. [read post]
28 May 2021, 9:05 pm by Coral Beach
The budget request also seeks increases to help address complex challenges facing the country such as the ongoing opioid crisis and promoting health equity among underserved communities,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
16 May 2021, 9:05 pm by Dan Flynn
(D-GA), have sent a letter to Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock, M.D., requesting transparency related to the budget for food safety programs at the FDA. [read post]
3 May 2021, 4:45 am by SHG
With these actions, the FDA will help significantly reduce youth initiation, increase the chances of smoking cessation among current smokers, and address health disparities experienced by communities of color, low-income populations, and LGBTQ+ individuals, all of whom are far more likely to use these tobacco products,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
21 Feb 2021, 9:05 pm by News Desk
Acting USDA Secretary Kevin Shea and Acting FDA Commissioner Janet Woodcock, M.D., issued a statement that takes exception to China’s latest contention about the origins of the coronavirus pandemic. [read post]
4 May 2020, 6:34 am by Salvi, Schostok & Pritchard P.C.
“Since we don’t know how or for how long the product might have been stored, we decided that it should not be available to consumers and patients unless its quality can be assured,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
14 Oct 2019, 10:59 am by silverman_admin
Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research states,  “We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. [read post]
13 Oct 2016, 6:12 am by m zamora
“Teething can be managed without prescription or over-the-counter remedies,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
13 Oct 2016, 6:12 am by m zamora
“Teething can be managed without prescription or over-the-counter remedies,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
13 Oct 2016, 6:12 am by m zamora
“Teething can be managed without prescription or over-the-counter remedies,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
13 Oct 2016, 6:12 am by m zamora
“Teething can be managed without prescription or over-the-counter remedies,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]